ATE179074T1 - Zusammensetzungen und verfahren zur verhinderung der adhäsionbildung - Google Patents

Zusammensetzungen und verfahren zur verhinderung der adhäsionbildung

Info

Publication number
ATE179074T1
ATE179074T1 AT92924282T AT92924282T ATE179074T1 AT E179074 T1 ATE179074 T1 AT E179074T1 AT 92924282 T AT92924282 T AT 92924282T AT 92924282 T AT92924282 T AT 92924282T AT E179074 T1 ATE179074 T1 AT E179074T1
Authority
AT
Austria
Prior art keywords
rgd
compositions
methods
adhesion formation
peptide
Prior art date
Application number
AT92924282T
Other languages
English (en)
Inventor
Gere Stodder Dizerega
Kathleen Elizabeth Rodgers
Original Assignee
Univ Southern California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Southern California filed Critical Univ Southern California
Application granted granted Critical
Publication of ATE179074T1 publication Critical patent/ATE179074T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT92924282T 1991-11-07 1992-11-06 Zusammensetzungen und verfahren zur verhinderung der adhäsionbildung ATE179074T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78923191A 1991-11-07 1991-11-07

Publications (1)

Publication Number Publication Date
ATE179074T1 true ATE179074T1 (de) 1999-05-15

Family

ID=25146991

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92924282T ATE179074T1 (de) 1991-11-07 1992-11-06 Zusammensetzungen und verfahren zur verhinderung der adhäsionbildung

Country Status (8)

Country Link
US (1) US5629294A (de)
EP (1) EP0667783B1 (de)
AT (1) ATE179074T1 (de)
AU (1) AU3064892A (de)
DE (1) DE69229004D1 (de)
TW (1) TW269634B (de)
WO (1) WO1993008818A1 (de)
ZA (1) ZA928607B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981719A (en) 1993-03-09 1999-11-09 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
DE19529909C2 (de) * 1995-08-15 1998-04-09 Fresenius Ag Wässrige Spüllösung
EP0793965A3 (de) * 1996-02-29 1999-02-24 Tano, Yasuo Prophylaktische/therapeutische Zusammensetzung für Nachstar
JP4234803B2 (ja) * 1997-10-27 2009-03-04 久光製薬株式会社 薬物放出速度が制御された医薬組成物
JP2003513682A (ja) * 1998-07-24 2003-04-15 ファーマカル、バイオテクノロジーズ、インコーポレーテッド 骨組織復元システムおよび方法
US6730775B1 (en) 1999-03-23 2004-05-04 University Of Southern California Methods for limiting scar and adhesion formation
US6312725B1 (en) 1999-04-16 2001-11-06 Cohesion Technologies, Inc. Rapid gelling biocompatible polymer composition
AU771328B2 (en) * 1999-06-01 2004-03-18 Vivolution A/S Fibrin sealants providing less inflammatory response and methods using same
US20010053766A1 (en) * 2000-02-11 2001-12-20 Janardan Kumar Method of treating disorders of the eye
DE602004026944D1 (de) * 2003-03-28 2010-06-10 Fujifilm Mfg Europe Bv RGD-angereicherte gelatineähnliche Proteine zur Verhinderung der Blutplättchenaggregation
JP2007512347A (ja) * 2003-11-26 2007-05-17 デューク・ユニバーシティー 緑内障を予防するかまたは治療する方法
CN104174071A (zh) 2004-04-28 2014-12-03 安希奥设备国际有限责任公司 用于形成交联生物材料的组合物和系统及关联的制备方法与用途
CN101379082A (zh) 2006-01-19 2009-03-04 爱吉恩公司 治疗血管相关疾病的包含肽的药物组合物
US9101581B2 (en) 2008-10-27 2015-08-11 Eyegene Inc. Method for treating vascular-related disease
EP1984391A4 (de) * 2006-01-19 2009-08-12 Eyegene Inc Peptidhaltige pharmazeutische zusammensetzung zur behandlung von mit dem gefässsystem in zusammenhang stehenden krankheiten
AU2008303922A1 (en) * 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Use of the peptide His-Ser-Leu-Gly-Lys-Trp-Leu-Gly-His-Pro-Asp-Lys-Phe alone or in combination with the peptide Gly-Ard-Gly-Asp-Asn-Pro-OH as a therapeutic agent
WO2009033730A2 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratoires Ag Peptide gxgrgdspca as a therapeutic agent
JP2010538979A (ja) * 2007-09-11 2010-12-16 モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト Ｓ．Ｐｎｅｕｍｏｎｉａｅの感染等を処置するための治療剤としての、ＲＧＤＳＰＡＳＳＫＰ、および随意的なアンギオテンシンＩＩの使用
WO2009033665A2 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of a rgd-peptide and/or parathyroid hormone (1-34 ) as anti-hiv agent
WO2010008792A1 (en) * 2008-06-24 2010-01-21 Yale University Nanoparticles for use as synthetic platelets and therapeutic agent delivery vehicles
US9555071B2 (en) * 2012-06-13 2017-01-31 Thien Nguyen Methods and compositions for the treatment of axonal and neuronal degeneration

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4614517A (en) * 1982-08-04 1986-09-30 La Jolla Cancer Research Foundation Tetrapeptide
US4517686A (en) * 1982-08-04 1985-05-21 La Jolla Cancer Research Foundation Polypeptide
US4589881A (en) * 1982-08-04 1986-05-20 La Jolla Cancer Research Foundation Polypeptide
US4792525A (en) * 1982-08-04 1988-12-20 La Jolla Cancer Research Foundation Tetrapeptide
US4661111A (en) * 1982-08-04 1987-04-28 La Jolla Cancer Research Foundation Polypeptide
US4578079A (en) * 1982-08-04 1986-03-25 La Jolla Cancer Research Foundation Tetrapeptide
US4746508A (en) * 1983-06-06 1988-05-24 Beth Israel Hospital Assn. Drug administration
US5352664A (en) * 1986-10-31 1994-10-04 Board Of Regents, The University Of Texas System Thrombin derived polypeptides; compositions and methods for use
DE3781263T2 (de) * 1986-12-15 1993-04-08 Inst Nat Sante Rech Med Peptid-derivate und deren verwendung in der therapie.
US4857508A (en) * 1987-12-03 1989-08-15 Monsanto Company Novel platelet-aggregation inhibitor peptide derivatives
JPH02240020A (ja) * 1989-01-26 1990-09-25 Childrens Medical Center Corp:The 外科的切除後の腫瘍再発阻止剤
NZ235563A (en) * 1989-10-13 1993-04-28 Merck & Co Inc Fibrinogen receptor antagonist and pharmaceutical composition
NZ235564A (en) * 1989-10-13 1993-10-26 Merck & Co Inc Fibrinogen receptor antagonist and pharmaceutical compositions
US5169833A (en) * 1989-12-15 1992-12-08 G. D. Searle & Co. Substituted cyclic pentapeptides

Also Published As

Publication number Publication date
AU3064892A (en) 1993-06-07
US5629294A (en) 1997-05-13
EP0667783A4 (de) 1995-04-25
EP0667783A1 (de) 1995-08-23
DE69229004D1 (de) 1999-05-27
TW269634B (de) 1996-02-01
WO1993008818A1 (en) 1993-05-13
ZA928607B (en) 1993-06-07
EP0667783B1 (de) 1999-04-21

Similar Documents

Publication Publication Date Title
DE69229004D1 (de) Zusammensetzungen und verfahren zur verhinderung der adhäsionbildung
FI945912A0 (fi) Proteinoidikantajat ja menetelmät niiden valmistamiseksi sekä niiden käyttö
Koenigs et al. Induced apical closure of permanent teeth in adult primates using a resorbable form of tricalcium phosphate ceramic
DE69705746D1 (de) Injizierbare depotgelzubereitung und herstellungsverfahren
ATE261278T1 (de) Mikrokapseln zum verabreichen von neuroaktiven wirkstoffen
DK0754034T3 (da) Brusende farmaceutiske formuleringer indeholdende biologisk nedbrydelige mikrokapsler med kontrolleret afgivelse
ATE122879T1 (de) Verabreichungsformen für pharmaka.
RU2004111596A (ru) Офтальмические композиции в форме депо для периокулярного или субконъюнктивального введения
ATE211387T1 (de) Oral 1alpha-hydroxyprevitamin d
ITPD910229A1 (it) Tessuto non tessuto essenzialmente costituito da derivati dell'acido ialuronico
NO305581B1 (no) Anvendelse av et benaktivt fosfonat i kombinasjon med et °strogenhormon, og preparat i enhetsdoseform for behandling av osteoporose
IE61346B1 (en) A permeable material to fit around the teeth or gums of a mammal
ATE171869T1 (de) Film zur lokalen arzneistoffabgabe für periodontale behandlung
ATE161423T1 (de) Verwendung von phosphinate zur behandlung der osteoporose
DE69426530D1 (de) Pharmazeutische zusammensetzung zur förderung der gewebeheilung und -regenerierung und darreichungssatz
ATE226428T1 (de) Verfahren zur herstellung von pharmazeutischen zusammensetzungen
ATE289506T1 (de) Hemmung der tnf-aktivität mit zusammensetzungen enthaltend heparin und lösliche tnf rezeptoren
FR2686250B1 (de)
Baghdady et al. Traumatized anterior teeth as related to their cause and place
BR9804768A (pt) Droga e aplicação de uma mistura
Carroll et al. The histologic effect of topically applied acetylsalicylic acid on bone healing in rats
Nawata et al. Bone Regeneration in Femoral Defect Filled with Fibrin Sealant. An Experimental Study
DE69927599D1 (de) Verwendung von wachstumshormon und analoga davon für die behandlung von säugern mit familiärer hypercholesterolämie
IGARI An experimental study on the bone bridging induced by autogenous iliac bone grafts into artificial maxillary alveolar clefts in dogs The comparison of cordco-cancellous bone block and particulate cancellous bone and marrow
IT1283134B1 (it) Derivati sintetici e semisintetici di somatostatine utili nella stimolazione della crescita corporea, in particolare in

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties